Search research articles
Contact Us
Filters
Showing results (281-290 of 365) with videos related to
Page
of 37
Sort By:
The American Journal of Cardiology
|
May 29, 2012
Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure
Ravi V Shah, Robert K Altman, Mi Young Park, et al.
The Journal of Biological Chemistry
|
February 9, 2017
Central Regulatory Role for SIN1 in Interferon γ (IFNγ) Signaling and Generation of Biological Responses
Barbara Kroczynska, Gavin T Blyth, Robert L Rafidi, et al.
Heart Rhythm
|
August 10, 2014
Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes
Daniel J Friedman, Gaurav A Upadhyay, Alefiyah Rajabali, et al.
Blood Cancer Journal
|
February 4, 2017
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes
R T Swords, J Watts, H P Erba, et al.
Molecular Cancer
|
June 10, 2010
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
Molly K Altman, Vashisht Gopal, Wei Jia, et al.
British Journal of Haematology
|
March 4, 2015
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study
Ronan T Swords, Harry P Erba, Daniel J DeAngelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma
A M Evens, J K Altman, B B Mittal, et al.
Bioorganic & Medicinal Chemistry
|
July 21, 2015
Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma
Mandi M Murph, Guowei W Jiang, Molly K Altman, et al.
Leukemia & Lymphoma
|
April 24, 2013
Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease
Ali Tabarroki, Valeria Visconte, Heesun J Rogers, et al.
Blood Cancer Journal
|
November 25, 2025
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide
Wei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, et al.
Page
of 37
Search research articles
Search
Showing results (281-290 of 365) with videos related to
Sort By:
Page
of 37
The American Journal of Cardiology
|
May 29, 2012
Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure
Ravi V Shah, Robert K Altman, Mi Young Park, et al.
The Journal of Biological Chemistry
|
February 9, 2017
Central Regulatory Role for SIN1 in Interferon γ (IFNγ) Signaling and Generation of Biological Responses
Barbara Kroczynska, Gavin T Blyth, Robert L Rafidi, et al.
Heart Rhythm
|
August 10, 2014
Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes
Daniel J Friedman, Gaurav A Upadhyay, Alefiyah Rajabali, et al.
Blood Cancer Journal
|
February 4, 2017
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes
R T Swords, J Watts, H P Erba, et al.
Molecular Cancer
|
June 10, 2010
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
Molly K Altman, Vashisht Gopal, Wei Jia, et al.
British Journal of Haematology
|
March 4, 2015
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study
Ronan T Swords, Harry P Erba, Daniel J DeAngelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma
A M Evens, J K Altman, B B Mittal, et al.
Bioorganic & Medicinal Chemistry
|
July 21, 2015
Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma
Mandi M Murph, Guowei W Jiang, Molly K Altman, et al.
Leukemia & Lymphoma
|
April 24, 2013
Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease
Ali Tabarroki, Valeria Visconte, Heesun J Rogers, et al.
Blood Cancer Journal
|
November 25, 2025
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide
Wei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, et al.
Page
of 37